Picture of Cartesian Therapeutics logo

RNAC — Cartesian Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Selecta Biosciences Inc expected to post a loss of 11  cents a share - Earnings Preview

* Selecta Biosciences Inc  SELB.OQ   SELB.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 5. 
    * The Watertown Massachusetts-based  company is expected to
report
 a 18.7% increase in revenue to $13.116 million from $11.05
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Selecta Biosciences
Inc
is for a loss of 11 cents per share. For the same quarter last
year, the company reported a loss of 22 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Selecta
Biosciences Inc is $8​, above​ its last closing price of $0.80.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.08       -0.07      0.03      Beat    141.2
 Sep. 30 2021  -0.03       -0.07      -0.16     Missed  -115.4
 Jun. 30 2021  -0.13       -0.12      0.04      Beat    134.1​
 Mar. 31 2021  -0.10       -0.12      -0.22     Missed  -80.3
 ​​Dec.        -0.09       -0.12      -0.14     Missed  -21
 31 2020                                                
 Sep. 30 2020  0.12        0.06       -0.09     Missed  -250​
 Jun. 30 2020  0.12        -0.01      -0.25     Missed  -3,233
                                                        .3
 Mar. 31 2020  -0.27       -0.28      -0.21     Beat    24.9
 This summary was machine generated May 3 at 15:19 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Cartesian Therapeutics

See all news